HSDT Solana Company's Mission is to maximize SOL per share on one of the most commercially viable blockchains for consumer applications while delivering consistent on-chain yield for investors HSDT enters into agreement with the Solana Foundation to establish its collaboration and commit to joint initiatives This signifies HSDT’s commitment to building a long-lasting institution that accelerates the growth of Solana and being a powerful advocate for Solana's development alongside the independent Solana Foun ...

Seeking an indication for gait and balance deficit in patients with chronic symptoms of stroke under its Breakthrough Device DesignationNEWTOWN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), today announced the filing of its U.S. Food and Drug Administration (FDA) 510(k) submission for the PoNS (Portable Neuromodulation Stimulator) device label expansion seeking an indication for gait and balance deficit in patients with chronic stroke symptoms. The submission was ...

Helius Medical Technologies, Inc. HSDT rallied in Monday's after-hours trading after announcing a Solana SOL/USD purchase worth $175 million.Helius Medical Kickstarts SOL Treasury PlayThe stock popped over 8% in after-hours, reversing its losses during the regular trading session. Helius Medical set its digital asset treasury strategy into motion, purchasing 760,000 SOL at an average price of $231, totaling $175.60 million.The neurotech company said it holds in excess of $335 million of cash, which it plans ...

Helius Medical Technologies, Inc. HSDT rallied in Monday's after-hours trading after announcing a Solana SOL/USD purchase worth $175 million.Helius Medical Kickstarts SOL Treasury PlayThe stock popped over 8% in after-hours, reversing its losses during the regular trading session. Helius Medical set its digital asset treasury strategy into motion, purchasing 760,000 SOL at an average price of $231, totaling $175.60 million.The neurotech company said it holds in excess of $335 million of cash, which it plans ...

Several biotech names posted strong gains in Monday's after-hours session, driven by clinical updates, strategic shifts, and upcoming catalysts. Volume spikes and late-day news helped push prices higher, setting the stage for potential follow-through in regular trading.Shares of Cassava Sciences (SAVA) surged in after-hours trading on Monday, climbing 37.1% to $3.18 following a regular session close of $2.32, which itself marked a 1.75% gain. The sharp move came on unusually high volume, with more than 11 ...

Shares in medical device and neurotech company Helius Medical Technologies dropped 16% on Monday amid news that the firm made its first Solana treasury acquisition.  Helius added 760,190 SOL at an average purchase price of $231, valuing its treasury at around $168 million. It still maintains around $335 million in cash which will help propel further additions to its Solana treasury.  “It has been gratifying to receive shows of support from multiple stakeholders across the Solana ecosystem, including staking ...

At 7:25 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening bell.For active traders, premarket trading offers a head start in spotting potential breakouts, reversals, or sharp price swings. These early moves often indicate where momentum may carry into the regular session, making premarket analysis a key part of the trading day.In the Green - Premarket GainersThe following stocks are trading highe ...

NEWTOWN, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (the "Company" or "HSDT"), today announced its first acquisition of Solana (“SOL”) tokens as part of its digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana Blockchain. The Company now holds over 760,190 SOL, with an average cost basis of $231. The Company also holds in excess of $335 million of cash, which it intends to use to further the digital asset treasur ...

公司融资与财务策略 - Helius Medical Technologies完成5亿美元私募融资 融资包括普通股和绑定认股权证 若全部认股权证行权可筹集超过12.5亿美元资金 [1] - 本轮融资由Pantera Capital和Summer Capital联合领投 使公司加密资产净值成为Solana生态国库实体中第二大 仅次于持有16亿美元资产的Forward Industries [2] - 公司明确将SOL作为核心储备资产 重点考虑Solana约7%的原生质押收益率优势 相较于比特币等无收益资产更具竞争力 [2] - 除质押外 公司计划选择性配置资产到去中心化金融和链上协议 在保持保守风险偏好的同时获取额外被动收益 [3] 行业质押数据变化 - Solana链上质押存款增长10.5百万枚SOL 价值约25亿美元 尽管期间价格下跌5% [4] - 质押数量从9月12日的400.8百万枚SOL上升至9月19日的411.3百万枚SOL [4] - 同期Rex Osprey的Solana质押ETF(SSK)带来近3亿美元资金流入 [5] - 质押参与度提升增强权益证明网络安全 表明大额持有者在价格下跌时选择锁定资产而非退出 [5] 市场交易与价格走势 - Solana现价236.82美元 日内下跌4.33% 跌破240美元的7日简单移动平均线关键支撑位 [6] - 币安平台日交易量7.11亿美元 较前日9.706亿美元下降27% 成交量萎缩暗示卖方缺乏信心 [7] - 若守住240美元支撑位 价格可能反弹至250美元以上 若跌破235美元则可能下探30日移动平均线214美元位置 [7] - MACD指标仍显示看涨信号 信号线12.52高于红色线11.43 但柱状图显示市场活动疲弱 [6]

Helius Medical Technologies (Nasdaq: HSDT) has closed on a $500 million PIPE as it pursues a Solana (SOL) Treasury Strategy.Solana is a high-performance blockchain that some predict will become the one blockchain to rule them all when it comes to institutional and financial services demands. Pantera Capital and Summer Capital led this charge, with Pantera founder Dan Morehead explaining he wants to create a DAT (digital asset treasury company) that is accessible to retail investors.In total, the project rai ...